Deep Cancer Screening - EDIM Cancer Detect (AP010 & TKTL1 Marker)

1. Innovative blood test for early-stage cancer screening using Epitope Detection in Monocytes (EDIM) principle. Only one blood draw required.

2. Key Markers: AP010 & TKTL1 indicate changes in cell function related to cancer development and spread.

3. Test highlights:
• No endoscopy required
• No complex procedures
• Covers multiple cancer types such as colon, lung, pancreas, etc.
• Can be used to monitor treatment effectiveness

4. Benefits for patients:
• Know cancer risk from early stages, increasing cure chances
• Enhance confidence and proactive prevention (Preventive Healthcare)
• Suitable for high-risk individuals or those with family history

What patients will know:
• Levels of AP010 and TKTL1 markers whether normal or suspicious
• Risk level assessment: Low / Moderate / High
• Early abnormal signals before tumors are detectable by imaging
• Trends to monitor treatment results (marker values decrease/stay stable after treatment)